From Sample to Insight: Technologies Driving the Future of Precision Oncology Assays
5. Jennings, L. J., et al. (2017). Guidelines for validation of next-generation sequencing–based oncology panels: A joint consensus recommendation of the Association for Molecular Pathology and College of American Pathologists. Journal of Molecular Diagnostics , 19(3), 341-365. https://doi.org/10.1016/j.jmoldx.2017.01.011 6. Belkadi, A., et al. (2015). Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants. Proceedings of the National Academy of Sciences of the United States of America , 112(17), 5473-5478. https://doi.org/10.1073/pnas.1418631112
7. Cuppen, E., et al. (2022). Implementation of whole- genome and transcriptome sequencing into clinical cancer care. JCO Precision Oncology , 6, e2200245. https:// doi.org/10.1200/PO.22.00245 8. Goodwin, S., McPherson, J. & McCombie, W. (2016). Coming of age: Ten years of next-generation sequencing technologies. Nature Reviews Genetics , 17(6), 333-351. https://doi.org/10.1038/nrg.2016.49 9. Malone, E. R., et al. (2020). Molecular profiling for precision cancer therapies. Genome Medicine , 12, 8. https://doi. org/10.1186/s13073-019-0703-1
White Paper
Advances in qPCR-based liquid biopsy for cancer detection & its applications Explore how qPCR-based liquid biopsy is transforming cancer detection with faster, less invasive diagnostics Download the white paper to learn about its clinical potential and applications.
20 | GENengnews.com
Powered by FlippingBook